Eli Lilly and Company
BG ˙ BUL ˙ US5324571083
SecurityBG:LLY / Eli Lilly and Company
InstitutionKimelman & Baird, LLC
Latest Disclosed Ownership40,324 shares
Latest Disclosed Value $ 37,088,576
Kimelman & Baird, LLC reports 3.71% decrease in ownership of LLY / Eli Lilly and Company

On May 13, 2026 - Kimelman & Baird, LLC filed a 13F-HR form disclosing ownership of 40,324 shares of Eli Lilly and Company (BG:LLY) valued at $37,088,576 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 41,878 shares of Eli Lilly and Company. This represents a change in shares of -3.71% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F ELI LILLY COM 532457108 40,324 -1,554 -3.71 37,089 -17.59 3.0521
2026-02-06 2025-12-31 13F ELI LILLY COM 532457108 41,878 -1,841 -4.21 45,005 34.92 3.4578
2025-11-25 2025-09-30 13F ELI LILLY COM 532457108 43,719 -564 -1.27 33,357 -3.37 2.6052
2025-08-12 2025-06-30 13F ELI LILLY COM 532457108 44,283 -440 -0.98 34,520 -6.54 2.8105
2025-05-13 2025-03-31 13F ELI LILLY COM 532457108 44,723 161 0.36 36,937 7.37 3.1381
2025-02-10 2024-12-31 13F ELI LILLY COM 532457108 44,562 7,972 21.79 34,402 6.12 2.7342
2024-11-15 2024-09-30 13F ELI LILLY COM 532457108 36,590 -1,370 -3.61 32,417 -5.68 2.5864
2024-08-19 2024-06-30 13F ELI LILLY COM 532457108 37,960 -26,040 -40.69 34,368 133.97 2.8347
2021-08-17 2021-06-30 13F Eli Lilly cs 532457108 64,000 0 0.00 14,689 105.24 1.3095
2019-12-10 2019-09-30 13F Eli Lilly cs 532457108 64,000 0 0.00 7,157 0.93 0.9924
2019-11-22 2019-06-30 13F Eli Lilly cs 532457108 64,000 0 0.00 7,091 -14.62 0.9866
2019-07-02 2019-03-31 13F Eli Lilly cs 532457108 64,000 0 0.00 8,305 12.14 1.1947
2019-02-15 2018-12-31 13F Eli Lilly cs 532457108 64,000 0 0.00 7,406 7.83 1.1522
2019-01-30 2018-09-30 13F Eli Lilly cs 532457108 64,000 0 0.00 6,868 25.76 0.8656
2019-01-24 2018-06-30 13F Eli Lilly cs 532457108 64,000 -110 -0.17 5,461 0.85 0.7169
2018-03-06 2017-12-31 13F Eli Lilly cs 532457108 64,110 110 0.17 5,415 -1.10 0.7697
2018-01-02 2017-09-30 13F Eli Lilly cs 532457108 64,000 -68,007 -51.52 5,475 -49.60 0.8161
2017-08-22 2017-06-30 13F Eli Lilly COM 532457108 132,007 -27,576 -17.28 10,864 -19.06 1.6464
2017-05-17 2017-03-31 13F Lilly Eli COM 532457108 159,583 -1,380 -0.86 13,423 13.38 2.0444
2017-04-10 2016-12-31 13F Eli Lilly COM 532457108 160,963 255 0.16 11,839 -8.21 1.9850
2016-12-13 2016-09-30 13F Eli Lilly COM 532457108 160,708 -32 -0.02 12,898 1.90 2.2676
2016-08-16 2016-06-30 13F Eli Lilly COM 532457108 160,740 288 0.18 12,658 9.56 2.3137
2016-05-13 2016-03-31 13F Eli Lilly COM 532457108 160,452 1,655 1.04 11,554 -13.65 2.1584
2016-02-12 2015-12-31 13F Eli Lilly COM 532457108 158,797 -4,665 -2.85 13,380 -1.96 2.5161
2015-08-12 2015-06-30 13F Eli Lilly cs 532457108 163,462 1,035 0.64 13,647 15.65 2.3276
2015-05-12 2015-03-31 13F Eli Lilly cs 532457108 162,427 7 0.00 11,800 5.31 2.1519
2015-02-12 2014-12-31 13F Eli Lilly cs 532457108 162,420 900 0.56 11,205 6.97 2.0195
2014-11-13 2014-09-30 13F Eli Lilly COM 532457108 161,520 100 0.06 10,475 4.38 1.9800
2014-08-14 2014-06-30 13F Eli Lilly cs 532457108 161,420 161,420 10,035 1.7661
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.